Drugs / ADMVA
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00252148 Comparator | Jan 2005 → Aug 2007 | HIV infectious disease | International AIDS Vaccine Initiative | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ADMVA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00252148 ↗ |
| Modality | Vaccine | “experimental HIV vaccine” NCT00252148 ↗ |
| Route | Intramuscular | “ADMVA or placebo was administered intramuscularly at months 0, 1 and 6 to 50 healthy adult volunteers not at high risk for HIV-1.” PMID 20111599 ↗ Jan 2010 |